1) Ames RS, Sarau HM, Chambers JK, et al:Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282-286, 1999
2) Douglas SA, Sulpizio AC, Piercy V, et al:Differential vasoconstrictor activity of human urotensin-Ⅱ in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131:1262-1274, 2000
3) Bottrill FE, Douglas SA, Hiley CR, et al:Human urotensin-Ⅱ is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130:1865-1870, 2000
4) Richards AM, Nicholls MG, Lainchbury JG, et al:Plasma urotensin Ⅱ in heart failure. Lancet 360:545-546, 2002
5) Douglas SA, Tayara L, Ohlstein EH, et al:Congestive heart failure and expression of myocardial urotensin Ⅱ. Lancet 359:1990-1997, 2002
6) Carmine Z, Mallamaci F:Urotensin Ⅱ:a cardiovascular and renal update. Curr Opin Nephrol Hypertens 17:199-204, 2008
7) Khan SQ, Bhandari SS, Quinn P, et al:Urotensin Ⅱ is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans. Int J Cardiol 117:323-328, 2007
8) Ravani P, Tripepi G, Pecchini P, et al:Urotensin Ⅱ is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney Int 73:95-101, 2008
9) Totsune K, Takahashi K, Arihara Z, et al:Increased plasma urotensin Ⅱ levels in patients with diabetes mellitus. Clin Sci(Lond) 104:1-5, 2003
10) Suguro T, Watanabe T, Kodate S, et al:Increased plasma urotensin-Ⅱ levels are associated with diabetic retinopathy and carotid atherosclerosis in type 2 diabetes mellitus. Clin Sci(Lond).2008 Mar 14
11) Suguro T, Watanabe T, Ban Y, et al:Increased human urotensin Ⅱ levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 20:211-217, 2007